BioXcel Therapeutics (BTAI) said Wednesday it has started a late-stage trial evaluating BXCL501 for potential treatment of agitation in Alzheimer's disease...
US stocks were set for a higher open Wednesday, recovering from a slump in the previous session amid concerns about the COVID-19 omicron variant and...
Health care stocks were edging higher premarket Wednesday as the iShares NASDAQ Biotechnology Index (IBB) was up 0.50% and the Health Care SPDR (XLV) was...
BioXcel Therapeutics (BTAI) reported that the US Food and Drug Administration has extended the Prescription Drug User Fee Act date for its review of the...
Aditxt (ADTX) shares slumped 21% after the company launched an underwritten public offering of common stock and warrants. BioXcel Therapeutics (BTAI)...
Telos (TLS) lagged sales estimates for Q3 and cut its full-year revenue guidance range to between $240 million and $245 million from the prior $283 million...
BioXcel Therapeutics (BTAI) shares were down almost 22% in Monday afternoon trading after Goldman Sachs downgraded its call on the clinical-stage drugmaker...
Oatly Group (OTLY) shares slumped 14% after the company reported a wider Q3 net loss. EVgo (EVGO) shares declined 8%. The company disclosed in a 10-Q...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...